Sbi Securities Co., Ltd. Standard Biotools Inc. Transaction History
Sbi Securities Co., Ltd.
- $3.25 Trillion
- Q4 2024
A detailed history of Sbi Securities Co., Ltd. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 162 shares of LAB stock, worth $236. This represents 0.0% of its overall portfolio holdings.
Number of Shares
162Holding current value
$236% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding LAB
# of Institutions
144Shares Held
270MCall Options Held
27.2KPut Options Held
34.1K-
Casdin Capital, LLC New York, NY71.3MShares$104 Million10.68% of portfolio
-
Viking Global Investors LP58.7MShares$85.6 Million0.44% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$31.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.3MShares$25.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY15.2MShares$22.3 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $115M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...